Compugen | CGEN - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Arca Biopharma USD 2.23M 1.08M 2025-12
aTyr Pharma USD 82.26M 77.46M 2025-12
Bio Path USD 199K 300K 2025-09
Brainstorm Cell Therapeutics USD 1.07M 64K 2025-09
Cara Therapeutics USD 4.64M 2.19M 2025-03
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
Immunic USD -0.24 0.03 2024-09
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Minerva Neurosciences USD 2.48M 58.79K 2024-09
RedHill Biopharma USD 4.48M 1.52M 2024-03
TherapeuticsMD USD 1.23M 90K 2024-06